About a-team Marketing Services
The knowledge platform for the financial technology industry

A-Team Insight Blogs

FTI Hires Celent Analyst For Competetive Research

Subscribe to our newsletter

Financial Technologies International has hired Fritz McCormick as a competitive research analyst, dealing with marketing and strategic policy. Formerly an analyst at Boston-based Celent Communications he will be working out of FTI’s Boston and New York offices.

Subscribe to our newsletter

Related content

WEBINAR

Recorded Webinar: Deploying cloud solutions in modern trading infrastructures

Cloud technology and other hosted solutions are finding increasing favour in in modern trading infrastructures, but how best can they be deployed and what can they deliver? The webinar will discuss the challenges and opportunities of cloud and hosted trading solutions, and detail best practice approaches to deployment. Listen to the webinar to find out...

BLOG

Trading Up: Helping Our Youngsters Get What We Do

By Andrew Delaney, President, A-Team Group. We hear it time and time again – at our conferences, on our roundtables and from our advisory boards: our beloved financial data and technology industry is suffering from an acute skills shortage. Flip to the other side of the coin, and employers and parents alike fret about the...

EVENT

TradingTech Summit London

Now in its 15th year the TradingTech Summit London brings together the European trading technology capital markets industry and examines the latest changes and innovations in trading technology and explores how technology is being deployed to create an edge in sell side and buy side capital markets financial institutions.

GUIDE

Alternative Trading Systems Directory 2010

The year since we launched our first edition of the A-Team Alternative Trading Directory has passed by in a flash (no pun intended). And while the rate of expansion of the alternative trading system sector may have slowed – even consolidated somewhat – in the more established centres, their onward march continues both in terms of credibility, and of uptake...